US 6965017
Melanoma antigens and their use in diagnostic and therapeutic methods
expired A61KA61K2039/5256A61K2039/53
Quick answer
US patent 6965017 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/5256, A61K2039/53, A61K2239/31, A61K2239/38